Evidence map›Paper›PMID 37072512›Full record

ArticleClinical rheumatology2023

Senescent CD4

Luis M Amezcua-Guerra, Fernanda Espinosa-Bautista, Karen Hopf-Estandía, Melisa Valdivieso-Ruiz, Dania Coronel, Sandra Robledo, Varna Ramos-Rosillo, María Del Rocío Martínez-Alvarado, Mariana Patlán, Araceli Páez and 5 more

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical rheumatology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Luis M Amezcua-GuerraImmunology Department, Instituto Nacional de Cardiología Ignacio Chávez, Juan Badiano 1, Sección XVI, Tlalpan, 14080, Mexico City, Mexico. lmamezcuag@gmail.com.ORCID http://orcid.org/0000-0002-6258-5732
Fernanda Espinosa-BautistaImmunology Department, Instituto Nacional de Cardiología Ignacio Chávez, Juan Badiano 1, Sección XVI, Tlalpan, 14080, Mexico City, Mexico.
Karen Hopf-EstandíaImmunology Department, Instituto Nacional de Cardiología Ignacio Chávez, Juan Badiano 1, Sección XVI, Tlalpan, 14080, Mexico City, Mexico.
Melisa Valdivieso-RuizRheumatology Division, Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, Mexico City, Mexico.
Dania CoronelImmunology Department, Instituto Nacional de Cardiología Ignacio Chávez, Juan Badiano 1, Sección XVI, Tlalpan, 14080, Mexico City, Mexico.
Sandra RobledoImmunology Department, Instituto Nacional de Cardiología Ignacio Chávez, Juan Badiano 1, Sección XVI, Tlalpan, 14080, Mexico City, Mexico.
Varna Ramos-RosilloImmunology Department, Instituto Nacional de Cardiología Ignacio Chávez, Juan Badiano 1, Sección XVI, Tlalpan, 14080, Mexico City, Mexico.
María Del Rocío Martínez-AlvaradoEndocrinology Department, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
Mariana PatlánUNAM/INC Translational Research Unit, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.ORCID http://orcid.org/0000-0002-6660-7388
Araceli PáezUNAM/INC Translational Research Unit, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.ORCID http://orcid.org/0000-0003-4688-8271
Luis H SilveiraRheumatology Department, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.ORCID http://orcid.org/0000-0001-5764-9343
Claudia Tavera-AlonsoCore Lab, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
Felipe MassóUNAM/INC Translational Research Unit, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.ORCID http://orcid.org/0000-0001-8671-3367
Carina Soto-FajardoRheumatology Division, Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, Mexico City, Mexico.ORCID http://orcid.org/0000-0001-6148-7789
Carlos PinedaRheumatology Division, Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, Mexico City, Mexico.ORCID http://orcid.org/0000-0003-0544-7461
Instituto Nacional de Cardiología · MXInstituto Nacional de Rehabilitación · MXUniversidad Autónoma Metropolitana · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To characterize CD4

Indexed as

CD28 AntigensHyperuricemiaAllopurinolCD4-Positive T-LymphocytesHumansLeukocytes, MononuclearNuclear Receptor Subfamily 1, Group F, Member 3PhenotypePilot ProjectsProof of Concept StudyUric AcidAllopurinolCD28 AntigensNuclear Receptor Subfamily 1, Group F, Member 3Uric AcidAllopurinolCD28HyperuricemiaInflammationT cells

Identifiers

PMID37072512
OpenAlexW4366261928

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.